Theralase Technologies Inc.
PublicTheralase Technologies Inc. is now publicly traded
The data on this page reflects Theralase Technologies Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Aug 31, 2026
Total Funding Raised
$181,378
Company Overview
Theralase Technologies Inc. is a pharmaceutical and medical device company that researches, develops, and commercializes light-activated photo dynamic compounds for cancer treatment and super-pulsed laser technology for pain management.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Theralase Technologies Inc. Comparables
Compare Theralase Technologies Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enabled Therapeutics | 69% | |
| Prokarium | 61% | |
| Dr. I&B Co., Ltd. | 57% |
Theralase Technologies Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Aug 31, 2026 | ||||
| Private Placement | May 27, 2026 |
Theralase Technologies Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access